LATEST ARTICLES

Moah Soan, DVM, PhD

Home » Moah Soan, DVM, PhD Researcher Spotlight: Moah Soan, DVM, PhD ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Jaime Peykoff Follicular Lymphoma Fellow Breakthrough therapies such as chimeric antigen receptor (CAR) T-cell therapies and bispecific antibodies have transformed the care of patients with follicular lymphoma (FL) such that many patients now experience deep and meaningful remissions. A...

Vignesh Shanmugam, MD

Home » Vignesh Shanmugam, MD Researcher Spotlight: Vignesh Shanmugam, MD BRIGHAM AND WOMEN’S HOSPITAL, INC. Tom Condon Family Fellow In many types of lymphoma, such as follicular lymphoma (FL), tumor cells are embedded in a rich microenvironment of non-malignant cells with which they regularly interact. The nature of these interactions has not been well studied, though, and Dr....

Michael Schneider, MD, PhD

Home » Michael Schneider, MD, PhD Researcher Spotlight: Michael Schneider, MD, PhD THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA Treatment of lymphoma has been revolutionized by the development of chimeric antigen receptor (CAR) T-cell therapies, which elicit robust responses in many patients. However, a large number of patients still relapse after CAR T cell therapy, and Dr....

Benedikt Pelzer, MD

Home » Benedikt Pelzer, MD Researcher Spotlight: Benedikt Pelzer, MD WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY The Levine Family Fellowship Marginal zone lymphoma (MZL) is a slow-growing type of cancer that can eventually transform into a more aggressive diffuse B-cell lymphoma (DLBCL) in a subset of patients. Both MZL and DLBCL are characterized by a high frequency of...

Atish Kizhakeyil, PhD

Home » Atish Kizhakeyil, PhD Researcher Spotlight: Atish Kizhakeyil, PhD UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER Alterations in the DTX1 gene are highly prevalent in diffuse large B-cell lymphoma (DLBCL), but their clinical significance remains unclear. Using animal models and advanced genomic technologies, Dr. Kizhakeyil’s research is focused on characterizing these changes to better understand how...